110 related articles for article (PubMed ID: 34457094)
1. Impact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeria.
David EA; Soremekun RO; Abah IO; Aderemi-Williams RI
Pharm Pract (Granada); 2021; 19(3):2402. PubMed ID: 34457094
[TBL] [Abstract][Full Text] [Related]
2. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a pharmacist-led structured group-based intervention in improving medication adherence and glycaemic control among type 2 diabetes mellitus patients: A randomized controlled trial.
Ting CY; Ahmad Zaidi Adruce S; Lim CJ; Abd Jabar AHA; Ting RS; Ting H; Osman NA; Ngau E; Talin BA; Muhammad M; Loo SC; Lim SE; Hassali MA
Res Social Adm Pharm; 2021 Feb; 17(2):344-355. PubMed ID: 32327398
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.
Fink RM; Mooney EV; Saseen JJ; Billups SJ
Pharm Pract (Granada); 2019; 17(4):1618. PubMed ID: 31897259
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial.
Aguiar PM; da Silva CHP; Chiann C; Dórea EL; Lyra DP; Storpirtis S
J Eval Clin Pract; 2018 Feb; 24(1):22-30. PubMed ID: 27452158
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Addition of Pharmacist Management to a Medication Assistance Program in Patients with Hypertension and Diabetes Resistant to Usual Care.
Smith AM; Hamann GL; Campbell JD; Sprabery LR
J Pharm Pract; 2022 Aug; 35(4):606-611. PubMed ID: 33739190
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of physical leisure time activities on glycaemic control in adult patients with diabetes type 2: A Systematic Review.
Pai LW; Chang PY; Chen W; Hwu YJ; Lai CH
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-20. PubMed ID: 27820154
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist-led group medical appointment model in type 2 diabetes.
Taveira TH; Friedmann PD; Cohen LB; Dooley AG; Khatana SA; Pirraglia PA; Wu WC
Diabetes Educ; 2010; 36(1):109-17. PubMed ID: 19966072
[TBL] [Abstract][Full Text] [Related]
10. Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial.
Wu WC; Taveira TH; Jeffery S; Jiang L; Tokuda L; Musial J; Cohen LB; Uhrle F
PLoS One; 2018; 13(4):e0195898. PubMed ID: 29672567
[TBL] [Abstract][Full Text] [Related]
11. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist-led intervention in treatment non-adherence and associated direct costs of management among ambulatory patients with type 2 diabetes in southwestern Nigeria.
Ipingbemi AE; Erhun WO; Adisa R
BMC Health Serv Res; 2021 Sep; 21(1):1000. PubMed ID: 34551779
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial.
Jameson JP; Baty PJ
Am J Manag Care; 2010 Apr; 16(4):250-5. PubMed ID: 20394460
[TBL] [Abstract][Full Text] [Related]
14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
15. Impact of Pharmacist-Led Diabetes Self-Care Education on Patients With Type 2 Diabetes in Pakistan: A Randomized Controlled Trial.
Bukhsh A; Khan TM; Phisalprapa P; Duangjai A; Saokaew S; Nawaz MS; Ahmed HS; Goh BH
Front Pharmacol; 2022; 13():754999. PubMed ID: 35222018
[No Abstract] [Full Text] [Related]
16. Pilot Mobile Phone Intervention in Promoting Type 2 Diabetes Management in an Urban Area in Ghana: A Randomized Controlled Trial.
Asante E; Bam V; Diji AK; Lomotey AY; Owusu Boateng A; Sarfo-Kantanka O; Oparebea Ansah E; Adjei D
Diabetes Educ; 2020 Oct; 46(5):455-464. PubMed ID: 32998649
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults.
Taveira TH; Dooley AG; Cohen LB; Khatana SA; Wu WC
Ann Pharmacother; 2011 Nov; 45(11):1346-55. PubMed ID: 22028418
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial.
Mourão AO; Ferreira WR; Martins MA; Reis AM; Carrillo MR; Guimarães AG; Ev LS
Int J Clin Pharm; 2013 Feb; 35(1):79-86. PubMed ID: 23161124
[TBL] [Abstract][Full Text] [Related]
19. Patient-centered medical home pharmacists' impact on composite quality care measures for patients with uncontrolled type 2 diabetes.
Schwenka N; Donovan A; Franck L; Coan C; McAdam-Marx C; Shin E
J Am Pharm Assoc (2003); 2023; 63(5):1545-1552.e4. PubMed ID: 37301508
[TBL] [Abstract][Full Text] [Related]
20. Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic.
Alghadeer SM; Alsuwayni B; Almuwayjid AK; Almadi MS; Mubarak AM; Khunayn RMB; Al-Arifi MN
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
